Select Page

HemEvolution

DISEASE STATE CAMPAIGN

Hemophilia B treatment has greatly improved over the years, but there is still a need for longer lasting, less disruptive options. Gene therapy is an exciting new innovation for the hemophilia B community, aiming to deliver years of sustained bleed protection with a single administration.

The HemEvolution campaign offers an educational, approachable, and engaging experience conveying the value and potential benefits of gene therapy for hemophilia B, preparing the world for a treatment that could liberate patients from their condition longer than ever thought possible.

72% of all website “request information” form submissions came from social lead generation campaigns Strong paid search engagement metrics with HCP exceeding a 3.05% high-value action conversion rate Email CRM emails drove significantly high engagement rates resulting in over 18-22% open rate and 2-5% click rate for patient and HCP audiences respectively

This site is intended to be reviewed on desktop browsers.